In addition, our studies provide proof-of-concept for novel potential strategies for senescence prevention through blockade of ATM-associated DNA damage response and/or inhibition of STAT1/STAT3 signaling in effector T cells for clinical immunotherapy against cancer and chronic infections. The gene discussed is STAT1; the disease is cancer.